Stocks · NASDAQ · Healthcare · United States

INCY — Incyte Genomics Inc

Incyte Genomics Inc (INCY) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 123.20 (-1.30% on the day), -0.0% over one month, +8.3% over three months, +46.9% over twelve months. The InvestMuse composite score is +6 on a −100 to +100 scale, a mixed read that ranks #640 of about 1,221 assets. The strongest of its nine dimensions are Fundamentals (+77) and Sector edge (+74); the weakest is Regime (hidden Markov model) (-75). Its volatility regime from the hidden Markov model is Calm. 31 news articles in the last 30 days carried an average tone of +0.29 (on −1 to +1).

Open the interactive read →Race INCY with $100k play money

The facts

Last close123.20 (September 29, 2026)
1 day / 1 month / 3 months / 12 months-1.30% / -0.0% / +8.3% / +46.9%
52-week range83.80 – 129.93
Composite score+6 / 100 · mixed view · rank #640
Volatility regime (HMM)Calm
Support levels61.00, 71.00, 83.00
Resistance levels110.00
Trailing P/E14.6
Market cap$23.6B

The nine dimensions

Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.

How this read is made

Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.

Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.